Topical interleukin-1 receptor antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Topical interleukin-1 receptor antagonist, covering 2017-05-08 to 2017-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Topical IL-1-Ra for Treatment of Corneal Neovascularization [Phase 1, Phase 2]